Income Statement Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 19/05/2026 BST			5-day change	1st Jan Change
287.50 ^DKK	+0.52%		-3.04%	-11.61%

05-19	Can Nvidia Do It Again?
05-19	Novo Nordisk highlights semaglutide for the treatment of silent liver disease	FW

097490fd7a6d08b5f15.cqqp-eaPIvLt8c4tjLZIRzB317mkDEhVvbIBpp8wh90.EJrqnKzNUcekuIdp5schdmMxoszIODwi8uVv7O93ypYdh9u8rbhGtbSk9g

Published financial data: NOVO NORDISK A/S

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	141B	177B	232B	290B	309B
Total Revenues	141B	177B	232B	290B	309B
Cost of Goods Sold, Total	23.66B	28.45B	35.76B	43.56B	54.38B
Gross Profit	117B	149B	196B	247B	255B
Selling General & Admin Expenses, Total	41.06B	50.68B	61.6B	67.37B	67.86B
R&D Expenses	17.2B	23.29B	31.03B	40.07B	46.16B
Other Operating Expenses	-456M	-1.08B	-119M	-476M	45M
Other Operating Expenses, Total	57.8B	72.89B	92.51B	107B	114B
Operating Income	59.34B	75.62B	104B	140B	141B
Interest Expense, Total	-289M	-378M	-542M	-1.64B	-4.21B
Interest And Investment Income	231M	239M	1.07B	1.84B	1.27B
Net Interest Expenses	-58M	-139M	527M	198M	-2.94B
Income (Loss) On Equity Invest.	-24M	-189M	81M	-17M	-17M
Currency Exchange Gains (Loss)	344M	-4.65B	1.65B	-1.02B	6.01B
Other Non Operating Income (Expenses)	-122M	-181M	-197M	-289M	-241M
EBT, Excl. Unusual Items	59.48B	70.46B	106B	139B	143B
Restructuring Charges	-	-	-	-	-9.37B
Merger & Related Restructuring Charges	-124M	-51M	-	-978M	-
Gain (Loss) On Sale Of Investments	296M	-587M	37M	-17M	71M
Asset Writedown	-573M	-760M	-1.41B	-10.56B	-3.59B
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	59.08B	69.06B	105B	127B	131B
Income Tax Expense	11.32B	13.54B	20.99B	26.2B	28.11B
Earnings From Continuing Operations	47.76B	55.52B	83.68B	101B	102B
Net Income to Company	47.76B	55.52B	83.68B	101B	102B
Net Income - (IS)	47.76B	55.52B	83.68B	101B	102B
Net Income to Common Incl Extra Items	47.76B	55.52B	83.68B	101B	102B
Net Income to Common Excl. Extra Items	47.76B	55.52B	83.68B	101B	102B
Per Share Items
Net EPS - Basic	10.4	12.26	18.67	22.67	23.06
Basic EPS - Continuing Operations	10.4	12.26	18.67	22.67	23.06
Basic Weighted Average Shares Outstanding	4.59B	4.53B	4.48B	4.45B	4.44B
Net EPS - Diluted	10.37	12.22	18.62	22.63	23.03
Diluted EPS - Continuing Operations	10.37	12.22	18.62	22.63	23.03
Diluted Weighted Average Shares Outstanding	4.61B	4.54B	4.49B	4.46B	4.45B
Normalized Basic EPS	8.09	9.72	14.79	19.47	20.18
Normalized Diluted EPS	8.07	9.69	14.75	19.43	20.15
Dividend Per Share	5.2	6.2	9.4	11.4	11.7
Payout Ratio	45.06	45.57	37.96	43.71	50.53
American Depositary Receipts Ratio (ADR)	0	0	0	0	0
Supplemental Items
EBITDA	63.55B	80.93B	110B	147B	153B
EBITA	60.21B	77.02B	106B	142B	147B
EBIT	59.34B	75.62B	104B	140B	141B
EBITDAR	64.86B	82.42B	112B	-	-
Effective Tax Rate - (Ratio)	19.17	19.6	20.05	20.6	21.53
Total Current Taxes	13.27B	18.17B	25B	32.25B	28.98B
Total Deferred Taxes	-1.94B	-4.63B	-4.01B	-6.05B	-876M
Normalized Net Income	37.18B	44.04B	66.28B	86.72B	89.64B
Interest on Long-Term Debt	-	-	-	-	-
Non-Cash Pension Expense	139M	185M	126M	156M	129M
Supplemental Operating Expense Items
Selling and Marketing Expenses	37.01B	46.22B	56.74B	62.09B	62.7B
General and Administrative Expenses	4.05B	4.47B	4.86B	5.28B	5.16B
Research And Development Expense From Footnotes	17.77B	24.05B	32.44B	48.06B	52.04B
Net Rental Expense, Total	1.3B	1.49B	1.83B	-	-
Imputed Operating Lease Interest Expense	163M	172M	301M	-	-
Imputed Operating Lease Depreciation	1.14B	1.32B	1.53B	-	-
Stock-Based Comp., Other (Total)	1.04B	1.54B	2.15B	2.29B	1.44B
Total Stock-Based Compensation	1.04B	1.54B	2.15B	2.29B	1.44B

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	10.72B	12.65B	14.39B	15.66B	26.46B
Short Term Investments	6.76B	10.92B	15.84B	10.65B	498M
Total Cash And Short Term Investments	17.48B	23.57B	30.23B	26.31B	26.96B
Accounts Receivable, Total	40.64B	50.56B	64.77B	71.95B	70.86B
Other Receivables	6.16B	6.94B	10.49B	15.46B	18.33B
Total Receivables	46.8B	57.5B	75.26B	87.41B	89.19B
Inventory	19.62B	24.39B	31.81B	40.85B	49.62B
Other Current Assets, Total	1.69B	2.73B	2.34B	6.33B	6.68B
Total Current Assets	85.6B	108B	140B	161B	172B
Gross Property Plant And Equipment	95.89B	111B	139B	215B	267B
Accumulated Depreciation	-40.52B	-44.76B	-47.62B	-52.4B	-58.94B
Net Property Plant And Equipment	55.36B	66.67B	90.96B	162B	208B
Long-term Investments	1.44B	1.34B	1.66B	2.68B	2.51B
Goodwill	4.35B	5.09B	4.46B	20.06B	19.84B
Other Intangibles, Total	38.82B	46.32B	55.94B	91.03B	110B
Deferred Tax Assets Long-Term	8.67B	13.43B	20.38B	24.63B	23.65B
Other Long-Term Assets, Total	267M	206M	1.43B	4.02B	5.86B
Total Assets	195B	241B	314B	466B	543B
Liabilities
Accounts Payable, Total	8.87B	15.59B	25.61B	28.85B	19.76B
Accrued Expenses, Total	50.57B	69.18B	100B	119B	917M
Short-term Borrowings	12.86B	480M	456M	5.79B	928M
Current Portion of Long-Term Debt	-	-	4.85B	5.98B	9.75B
Current Portion of Leases	822M	986M	1.17B	1.34B	1.34B
Current Income Taxes Payable	3.66B	7.09B	7.12B	9.72B	8.42B
Other Current Liabilities	22.74B	27.62B	30.43B	46.92B	175B
Total Current Liabilities	99.52B	121B	170B	218B	216B
Long-Term Debt	9.65B	20.78B	15.98B	84.25B	112B
Long-Term Leases	3.31B	3.54B	4.55B	5.43B	7.24B
Pension & Other Post Retirement Benefits	1.28B	762M	742M	903M	861M
Deferred Tax Liability Non Current	5.27B	7.06B	10.16B	5.43B	6.61B
Other Non Current Liabilities	4.73B	4.69B	6.84B	8.78B	6.78B
Total Liabilities	124B	158B	208B	322B	349B
Common Stock, Total	462M	456M	451M	446M	446M
Retained Earnings	72B	80.59B	105B	144B	195B
Treasury Stock	-6M	-6M	-5M	-2M	-2M
Comprehensive Income and Other	-1.71B	2.45B	1.28B	-1.41B	-1.7B
Total Common Equity	70.75B	83.49B	107B	143B	194B
Total Equity	70.75B	83.49B	107B	143B	194B
Total Liabilities And Equity	195B	241B	314B	466B	543B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.56B	4.5B	4.46B	4.44B	4.44B
ECS Total Common Shares Outstanding	4.56B	4.5B	4.46B	4.44B	4.44B
Book Value / Share	15.52	18.55	23.9	32.31	43.66
Tangible Book Value	27.58B	32.07B	46.16B	32.4B	63.99B
Tangible Book Value Per Share	6.05	7.13	10.35	7.29	14.4
Total Debt	26.64B	25.78B	27.01B	103B	131B
Net Debt	9.16B	2.21B	-3.22B	76.48B	104B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	-	-
Debt Equivalent Oper. Leases	10.42B	11.93B	14.66B	-	-
Equity Method Investments, Total	525M	327M	410M	400M	366M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	4.31B	6.39B	9.5B	13.37B	17.44B
Inventories - Work In Process, Total	12.28B	13.67B	17.6B	22.34B	25.86B
Inventories - Finished Goods, Total	5.28B	6.04B	7.22B	8.87B	11.99B
Land - (BS)	41.08B	43.4B	48.99B	62.14B	65.56B
Machinery, Total	43.72B	45.66B	49.93B	73.36B	71.13B
Full Time Employees	47.79K	54.39K	63.37K	76.3K	68.79K
Part Time Employees	686	792	949	1.05K	711
Accumulated Allowance for Doubtful Accounts (Supple)	1.43B	1.52B	1.79B	2.13B	1.99B

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	47.76B	55.52B	83.68B	101B	102B
Depreciation & Amortization - CF	4.24B	4.95B	5.46B	6.03B	8.14B
Amortization of Goodwill and Intangible Assets - (CF)	866M	1.4B	1.62B	2.26B	6.21B
Depreciation & Amortization, Total	5.11B	6.36B	7.08B	8.29B	14.35B
Amortization of Deferred Charges, Total - (CF)	200M	195M	213M	255M	318M
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-340M	124M	-	-5.08B	4.16B
Asset Writedown & Restructuring Costs	714M	809M	2.12B	10.56B	7.32B
(Income) Loss On Equity Investments - (CF)	24M	189M	-	17M	17M
Stock-Based Compensation (CF)	1.04B	1.54B	-	2.29B	1.44B
Other Operating Activities, Total	9.15B	19.48B	28.06B	15.64B	-14.66B
Change In Accounts Receivable	-12.91B	-9.92B	-14.21B	-7.18B	1.09B
Change In Inventories	-1.08B	-4.77B	-7.42B	-9.04B	-8.77B
Change In Accounts Payable	3.15B	6.72B	10.02B	3.24B	2.62B
Change in Other Net Operating Assets	2.18B	2.63B	-631M	982M	8.8B
Cash from Operations	55B	78.89B	109B	121B	119B
Capital Expenditure	-6.34B	-12.15B	-25.81B	-47.16B	-60.14B
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-18.28B	-7.08B	-	-82.16B	1B
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-1.05B	-2.61B	-13.09B	-4.14B	-29.97B
Investment in Marketable and Equity Securities, Total	-5.94B	-3.09B	-5B	4.58B	9.95B
Other Investing Activities, Total	4M	-	-	-	-
Cash from Investing	-31.6B	-24.92B	-43.89B	-129B	-79.16B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	22.16B	11.22B	-	79.39B	104B
Total Debt Issued	22.16B	11.22B	-	79.39B	104B
Long-Term Debt Repaid, Total	-6.69B	-13.62B	-1.47B	-6.34B	-79.19B
Total Debt Repaid	-6.69B	-13.62B	-1.47B	-6.34B	-79.19B
Repurchase of Common Stock	-19.45B	-24.09B	-29.92B	-20.18B	-1.39B
Common Dividends Paid	-21.52B	-25.3B	-31.77B	-44.14B	-51.76B
Common & Preferred Stock Dividends Paid	-21.52B	-25.3B	-31.77B	-44.14B	-51.76B
Cash from Financing	-25.49B	-51.8B	-63.16B	8.74B	-28.41B
Foreign Exchange Rate Adjustments	591M	-238M	-119M	455M	-727M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-1.51B	1.93B	1.74B	1.26B	10.81B
Supplemental Items
Cash Interest Paid	261M	272M	491M	612M	3.42B
Cash Income Tax Paid (Refund)	14.44B	14.52B	25.9B	29.64B	32.01B
Levered Free Cash Flow	43.83B	57.5B	54.1B	61.99B	377M
Unlevered Free Cash Flow	44.01B	57.73B	54.44B	63.01B	3.01B
Change In Net Working Capital	-7.96B	-17.13B	-18.91B	-16.06B	10.87B
Net Debt Issued / Repaid	15.47B	-2.41B	-1.47B	73.06B	24.74B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	21.85	21.69	23.39	22.41	17.43
Return on Total Capital	43.36	45.74	53.53	46.03	30.77
Return On Equity %	71.24	72	88.07	80.78	60.7
Return on Common Equity	71.24	72	88.07	80.78	60.7
Margin Analysis
Gross Profit Margin %	83.2	83.92	84.6	85	82.41
SG&A Margin	29.16	28.64	26.52	23.2	21.96
EBITDA Margin %	45.14	45.73	47.28	50.51	49.6
EBITA Margin %	42.76	43.53	45.47	48.94	47.51
EBIT Margin %	42.15	42.73	44.77	48.17	45.5
Income From Continuing Operations Margin %	33.92	31.38	36.03	34.78	33.14
Net Income Margin %	33.92	31.38	36.03	34.78	33.14
Net Avail. For Common Margin %	33.92	31.38	36.03	34.78	33.14
Normalized Net Income Margin	26.4	24.89	28.54	29.86	29
Levered Free Cash Flow Margin	31.13	32.49	23.29	21.35	0.12
Unlevered Free Cash Flow Margin	31.26	32.63	23.44	21.7	0.97
Asset Turnover
Asset Turnover	0.83	0.81	0.84	0.74	0.61
Fixed Assets Turnover	2.67	2.9	2.95	2.29	1.67
Receivables Turnover (Average Receivables)	4.12	3.88	4.03	4.25	4.33
Inventory Turnover (Average Inventory)	1.24	1.29	1.27	1.2	1.2
Short Term Liquidity
Current Ratio	0.86	0.89	0.82	0.74	0.8
Quick Ratio	0.65	0.67	0.62	0.52	0.54
Operating Cash Flow to Current Liabilities	0.55	0.65	0.64	0.56	0.55
Days Sales Outstanding (Average Receivables)	88.63	94.06	90.62	86.15	84.33
Days Outstanding Inventory (Average Inventory)	294.35	282.33	286.77	305.25	303.64
Average Days Payable Outstanding	107.59	134.38	174.07	189.45	106.63
Cash Conversion Cycle (Average Days)	275.38	242.01	203.32	201.96	281.34
Long Term Solvency
Total Debt/Equity	37.66	30.88	25.34	71.64	67.49
Total Debt / Total Capital	27.36	23.6	20.22	41.74	40.29
LT Debt/Equity	18.32	29.13	19.26	62.5	61.29
Long-Term Debt / Total Capital	13.31	22.25	15.37	36.41	36.6
Total Liabilities / Total Assets	63.63	65.4	66.12	69.2	64.26
EBIT / Interest Expense	205.33	200.05	191.86	85.29	33.42
EBITDA / Interest Expense	223.02	216.87	204.92	90.35	36.84
(EBITDA - Capex) / Interest Expense	201.1	184.74	157.3	61.59	22.54
Total Debt / EBITDA	0.41	0.31	0.24	0.69	0.85
Net Debt / EBITDA	0.14	0.03	-0.03	0.52	0.67
Total Debt / (EBITDA - Capex)	0.46	0.37	0.32	1.02	1.38
Net Debt / (EBITDA - Capex)	0.16	0.03	-0.04	0.76	1.1
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	10.91	25.68	31.26	25.03	6.43
Gross Profit, 1 Yr. Growth %	10.5	26.77	32.32	25.34	3.18
EBITDA, 1 Yr. Growth %	8.49	27.34	35.78	32.7	5.22
EBITA, 1 Yr. Growth %	8.75	27.93	37.2	33.69	4.02
EBIT, 1 Yr. Growth %	8.93	27.43	37.61	33.6	1.24
Earnings From Cont. Operations, 1 Yr. Growth %	13.33	16.27	50.71	20.68	1.43
Net Income, 1 Yr. Growth %	13.33	16.27	50.71	20.68	1.43
Normalized Net Income, 1 Yr. Growth %	10.82	18.46	50.62	29.96	4.11
Diluted EPS Before Extra, 1 Yr. Growth %	15.16	17.84	52.37	21.54	1.77
Accounts Receivable, 1 Yr. Growth %	46.55	24.4	28.11	11.08	-1.52
Inventory, 1 Yr. Growth %	5.85	24.3	30.44	28.41	21.48
Net Property, Plant and Equip., 1 Yr. Growth %	10.13	20.43	36.43	78.63	28.88
Total Assets, 1 Yr. Growth %	34.22	24.03	30.35	48.11	16.6
Tangible Book Value, 1 Yr. Growth %	-35.37	16.3	41.81	-29.81	95.91
Common Equity, 1 Yr. Growth %	11.72	18.01	27.64	34.65	35.24
Cash From Operations, 1 Yr. Growth %	5.87	43.43	38.06	11.07	-1.54
Capital Expenditures, 1 Yr. Growth %	8.76	91.73	112.46	82.76	27.51
Levered Free Cash Flow, 1 Yr. Growth %	157	31.17	-5.85	13.64	-99.38
Unlevered Free Cash Flow, 1 Yr. Growth %	154.42	31.17	-5.65	14.81	-95.12
Dividend Per Share, 1 Yr. Growth %	14.29	19.23	51.61	21.28	2.63
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	7.42	18.06	28.44	28.11	15.35
Gross Profit, 2 Yr. CAGR %	7.2	18.36	29.52	28.91	13.72
EBITDA, 2 Yr. CAGR %	6.24	17.55	31.23	34.46	17.66
EBITA, 2 Yr. CAGR %	6.61	18.1	32.36	35.67	17.4
EBIT, 2 Yr. CAGR %	6.33	18.2	32.52	36.01	15.89
Earnings From Cont. Operations, 2 Yr. CAGR %	10.73	14.79	32.37	34.86	10.64
Net Income, 2 Yr. CAGR %	10.73	14.79	32.37	34.86	10.64
Normalized Net Income, 2 Yr. CAGR %	10.52	14.95	33.67	40.33	15.91
Diluted EPS Before Extra, 2 Yr. CAGR %	12.52	16.49	34	36.08	11.21
Accounts Receivable, 2 Yr. CAGR %	27.73	35.02	26.24	19.29	4.59
Inventory, 2 Yr. CAGR %	5.46	14.7	27.33	29.42	24.9
Net Property, Plant and Equip., 2 Yr. CAGR %	4.65	15.16	28.18	56.11	51.36
Total Assets, 2 Yr. CAGR %	24.44	29.02	27.15	38.95	31.39
Tangible Book Value, 2 Yr. CAGR %	-27.01	-13.3	29.38	-0.23	17.75
Common Equity, 2 Yr. CAGR %	10.83	14.82	22.73	31.1	34.94
Cash From Operations, 2 Yr. CAGR %	8.43	23.23	40.72	23.83	4.58
Capital Expenditures, 2 Yr. CAGR %	-15.78	44.4	101.83	97.06	52.66
Levered Free Cash Flow, 2 Yr. CAGR %	27.93	84.1	11.02	3.83	-91.69
Unlevered Free Cash Flow, 2 Yr. CAGR %	27.86	83.17	11.14	4.47	-76.6
Dividend Per Share, 2 Yr. CAGR %	11.6	16.73	34.45	35.6	11.57
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.98	13.19	22.31	27.29	20.43
Gross Profit, 3 Yr. CAGR %	7.53	13.36	22.84	28.2	19.69
EBITDA, 3 Yr. CAGR %	7.49	12.85	23.31	32	23.63
EBITA, 3 Yr. CAGR %	8.41	13.29	24.13	33.1	23.89
EBIT, 3 Yr. CAGR %	7.89	12.95	24.32	33.18	22.97
Earnings From Cont. Operations, 3 Yr. CAGR %	7.33	12.54	25.7	28.35	22.65
Net Income, 3 Yr. CAGR %	7.33	12.54	25.7	28.35	22.65
Normalized Net Income, 3 Yr. CAGR %	7.82	13.1	25.76	32.71	26.74
Diluted EPS Before Extra, 3 Yr. CAGR %	9.19	14.27	27.4	29.71	23.52
Accounts Receivable, 3 Yr. CAGR %	21.28	26.61	32.67	20.97	11.91
Inventory, 3 Yr. CAGR %	6.3	11.4	19.73	27.69	26.72
Net Property, Plant and Equip., 3 Yr. CAGR %	9.74	9.67	21.86	43.18	46.21
Total Assets, 3 Yr. CAGR %	20.64	24.3	29.47	33.79	31.04
Tangible Book Value, 3 Yr. CAGR %	-16.1	-14.75	2.65	5.52	25.28
Common Equity, 3 Yr. CAGR %	10.92	13.17	18.94	26.58	32.46
Cash From Operations, 3 Yr. CAGR %	7.22	19.03	27.98	30.05	14.72
Capital Expenditures, 3 Yr. CAGR %	-13.05	10.79	64.24	95.26	70.44
Levered Free Cash Flow, 3 Yr. CAGR %	16.82	29	47.2	12.19	-81.29
Unlevered Free Cash Flow, 3 Yr. CAGR %	16.91	28.96	46.8	12.65	-62.66
Dividend Per Share, 3 Yr. CAGR %	8.47	14.09	27.36	29.91	23.58
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.72	9.64	15.74	18.94	19.48
Gross Profit, 5 Yr. CAGR %	4.37	9.56	15.84	19.35	19.16
EBITDA, 5 Yr. CAGR %	4.24	9.19	16.5	21.1	21.22
EBITA, 5 Yr. CAGR %	4.27	9.48	17.45	21.82	21.6
EBIT, 5 Yr. CAGR %	4.15	9.08	17.09	21.66	21.04
Earnings From Cont. Operations, 5 Yr. CAGR %	4.72	7.81	16.72	20.99	19.44
Net Income, 5 Yr. CAGR %	4.72	7.81	16.72	20.99	19.44
Normalized Net Income, 5 Yr. CAGR %	4.48	7.66	17.45	23.29	21.88
Diluted EPS Before Extra, 5 Yr. CAGR %	6.75	9.69	18.51	22.54	20.66
Accounts Receivable, 5 Yr. CAGR %	14.97	20.18	23.24	23.63	20.63
Inventory, 5 Yr. CAGR %	6.47	9.67	14.26	18.29	21.77
Net Property, Plant and Equip., 5 Yr. CAGR %	12.9	13.6	16.77	26.3	32.9
Total Assets, 5 Yr. CAGR %	14.8	18.71	23.21	29.97	30.23
Tangible Book Value, 5 Yr. CAGR %	-8.31	-7.16	-0.23	-8.95	8.44
Common Equity, 5 Yr. CAGR %	9.34	10.88	15.5	20.03	25.1
Cash From Operations, 5 Yr. CAGR %	2.63	13.89	19.54	20.93	18.05
Capital Expenditures, 5 Yr. CAGR %	-2.17	9.76	21.78	39.49	59.5
Levered Free Cash Flow, 5 Yr. CAGR %	8.96	21.89	14.5	18.27	-53.3
Unlevered Free Cash Flow, 5 Yr. CAGR %	9.02	21.93	14.6	18.54	-29.46
Dividend Per Share, 5 Yr. CAGR %	6.47	9.57	18.2	22.25	20.79